![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1424, 2004-01, pp. : 14-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Docetaxel regimen improves survival in early breast cancer
Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Trastuzumab improves survival in early breast cancer
Inpharma, Vol. 1, Iss. 1490, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Switching strategy improves overall survival in breast cancer
Inpharma, Vol. 1, Iss. 1550, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drugs & Therapy Perspectives, Vol. 23, Iss. 5, 2007-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Uracil/tegafur improves survival in node-negative breast cancer
Inpharma, Vol. 1, Iss. 1493, 2005-01 ,pp. :